Assessment of some risk factors for angiographically defined coronary artery disease in the Erbil Cardiac Center
Background and objective: There are many modifiable risk factors that are closely associated with coronary artery disease. The aim of this study was to assess the association between some coronary risk factors and the angiographically documented coronary artery disease.
Methods: This descriptive cross-sectional study was based on review of hospital records of 310 consecutive patients who underwent coronary angiography in Erbil Cardiac Center. A questionnaire was used to record patient’s demographic profile, coronary risk factors and the severity of stenosis in percentage.
Results: Of the 310 patients, 69.4% had evidence of coronary artery disease on coronary angiography. Male gender, age, diabetes, and smoking habit were strongly associated with angiographically documented coronary artery disease, while the association of hypertension and family history were not statistically significant. Only male gender was strongly associated with severity of coronary artery disease.
Conclusion: The angiographic extent of coronary artery disease was found to have the strongest positive correlation with male gender and the weakest with hypertension. The most important predictive factors for coronary artery disease positivity were age, diabetes and smoking status. Hypertension and family history of premature coronary artery disease did not prove to be either a significant predictor of coronary artery disease at coronary angiography or an important determinant of coronary artery disease severity.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012; 366:321.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-52.
Wilson PW. Established risk factors and coronary artery disease: The Framingham Study. Am J Hypertens 1994; 7:7S-12S.
Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837.
Ridker, PM. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? Ann Intern Med 1999; 130:933-7.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002; 106:3143-421.
Chobanian AV, Bakris GL, Black HR, Cushman WC. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289:2560-72.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998; 97:1095-102.
Canto JG, Iskandrian AE. Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA 2003; 290:947-9.
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290:891-7.
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290:898-904.
Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293:1868-74.
Ministry of Health. Annual report. Iraq: Ministry of Health; 2009.
Libby P. The Vascular Biology of Atherosclerosis. In:Libby P P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. Philadelphia: Saunder Elsevier; 2008. P. 985-1000.
Davidson CJ, Bonow RO. Cardiac catheterisation. In: Libby P P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. Philadelphia: Saunder Elsevier; 2008. P. 439-62.
Poma JJ. Coronary Arteriography & Cardiovascular Imaging. In:Libby PP, Bonow RO, Mann DL, Zipes DP, editors. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. Philadelphia: Saunder Elsevier; 2008. P. 465-508.
Anderson AJ, Barboriak JJ, Rimm AA: Risk factors andangiographically determined coronary occlusion. Am JEpidemiol 1978; 107(1):8-14.
Ning XH, Xiang XP, Lu N, Zhang YX, Wang WJ, Liu Y, et al. Relation of risk factors to coronaryartery stenosis severity in coronary atherosclerotic heartdisease. Zhonghua Yi XueZaZhi 2008; 88(18):1267-9.
Wang XL, Tam C, McCredie RM, Wilcken DE. Determinants ofseverity of coronary artery disease in Australian men and women.Circulation 1994; 89(5):1974-81.
Saleem T, Mohammad KH, Abdel-Fattah MM, Abbasi AH. Associationof glycosylated haemoglobin level and diabetes mellitusduration with the severity of coronary artery disease. DiabVascDis Res 2008; 5(3):184-9.
Zornitzki T, Ayzenberg O, Gandelman G, Vered S, Yaskil E, Faraggi D, et al. Diabetes, but notthe metabolic syndrome, predicts the severity and extent of coronaryartery disease in women. QJM 2007; 100(9):575-81.
O’Callaghan PA, Fitzgerald A, Fogarty J, Gaffney P, Hanbidge M, Boran G, et al. New and old cardiovascularrisk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially insmokers. Eur J Cardiovasc Prev Rehabil 2005; 12(6):542-7.
Peer A, Falkensammer G, Alber H, Kroiss A, Griesmacher A, Ulmer H,et al. Limited utilities of N-terminal pro B-type natriuretic peptide (NT-proBNP) and othernewer risk markers compared with traditional risk factors forprediction of significant angiographic lesions in stable coronaryartery disease. Heart 2009; 95(4): 297-303.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).